Evidence map›Paper›PMID 42490911›Full record

ArticleFrontiers in bioinformatics2026

Beyond presence and frequency: a determinant-level framework for interpreting AMR dissemination in One Health surveillance.

Varunkumar Asediya

Abstract read
In one paragraph

Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Varunkumar AsediyaFaculty of Biological and Veterinary Sciences, Institute of Veterinary Medicine, Nicolaus Copernicus University in Toruń, Toruń, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic sequencing is now routine in One Health antimicrobial resistance (AMR) surveillance, but reports often stop at presence and frequency and do not distinguish a determinant confined to one genomic background from one recurring across lineages, reservoirs, and reporting periods-patterns that warrant different action. We propose the Determinant Dissemination State (Dg-state), a determinant-level interpretation layer that classifies each resistance determinant as Contained, Emerging, Disseminating, or Abstain. We specify the complete decision rule under a single notation: six bounded evidentiary domains; a composite dissemination score with default weights; an uncertainty-adjusted score that discounts weak genomic context and thin sampling; an explicit sampling-adequacy gate; a two-stage classification separating confined recurrence from genuine cross-reservoir or cross-lineage spread; and a classification-stability measure. As a proof-of-concept, and with an accompanying reference implementation, we apply the framework to a literature-anchored simulated surveillance dataset with known ground truth, where it reproduces the intended labels and behaves robustly. Dg-state does not infer transmission; it provides an auditable, reproducible way to prioritise determinants for escalation, targeted resampling, and higher-resolution genomic investigation.

Indexed as

antimicrobial resistance (AMR)decision supportgenomic surveillancemobile genetic elementsone healthresistance determinantssampling denominators

Identifiers

PMID42490911
PMCPMC13375786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.